The late-breaking clinical trials session at the ISTH 2021 Congress featured a promising new anticoagulant for the prevention of VTE and some much needed evidence for duration of anticoagulation in children. Abelacimab after TKA Factor XI inhibition with a single intravenous dose of abelacimab after total knee arthroplasty is effective for the prevention of postoperative ...
VTE late breakers from ISTH 2021
By Mardi Chapman
26 Jul 2021